PERSPECTA

News from every angle

← Back to headlines

Wells Fargo Cuts Price Target on Sarepta Therapeutics (SRPT)

Wells Fargo has reduced its price target for Sarepta Therapeutics (SRPT) from $45 to $38.

1 Mar, 09:27 — 1 Mar, 09:27
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo2d ago

Wells Fargo Cuts PT on Sarepta Therapeutics (SRPT) to $38 From $45

Read full article →

Related Stories

27-Year-Old British Woman Saves €115K for Early Retirement Using 5 Tricks

22m ago

A low credit score could cost you nearly $400 in interest each year. Here's how to fix it

29m ago

PennantPark Investment Declares Dividend

31m ago

NASB Financial Declares Dividend

33m ago